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Introduction
Tuberculosis represents a major global health problem, 
well recognized in the Republic of Moldova (MD) [1]. Ac-
cording to the WHO report in 2015, 10.4 million new cases 
were reported worldwide, of which 5,9 million (56%) were 
among men, 5.5 million (34%) among women and 1.0 mil-
lion (10%) among children. Among all new tuberculosis cas-
es, 1.2 million (11%) were people living with HIV infection. 
Two thirds of all cases were living in 6 countries: India, Indo-
nesia, China, Nigeria, Pakistan and South Africa [17]. In the 
Republic of Moldova 4.211 cases were notifi ed in 2015, 3.608 
were new cases, 85% of them were tested by rapid diagnostic 
methods, 95% had known HIV status, 90% had pulmonary 
tuberculosis and 64% were bacteriological confi rmed [1].
Th e national implementation of the DOT (Directly 
Observed Treatment) strategy in the tuberculosis patient’s 
management determined the epidemic extension of primary 
drug-resistant infection in the population (2005 – 13%, 2006 
– 19%, 2007 – 18%, 2008 – 24%, 2009 – 22%, 2010 –25%, 
2011 –26%, 2012 – 24%, 2013 – 25%, 2014 –25% from the 
total registered MDR-TB cases) that in consequence con-
tributed to the reduction of treatment eff ectiveness (2005 – 
62%, 2006 – 62%, 2007 – 62%, 2008 – 58%, 2009 – 57%, 2010 
–52%, 2011 –62%, 2012 – 62%, 2013 – 62%) which was the 
lowest among the European region countries and lower in 
average by 20% compared with targeted 85% recommended 
by the WHO [1]. Th e low success rate was directly linked 
with the high rate of lost to follow-up patients: 2001-5.5%, 
2002-15.6%, 2003-10.5%, 2004-10.4%, 2005-10.9%, 2006-
11.7%, 2007-10.7%, 2008-7.4%, 2009-6.2%, 2010-7.9%, 
2011-7.7%, 2012 – 5.2% [1].
Th e standard treatment for new drug-susceptible tu-
berculosis, according to WHO recommendations in MD is 
used since 2000 as a part of DOT strategy and lasts 6 months 
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Abstract
Background: The highest rate of patients with the low disease outcome is represented by the lost to follow-up and died cases. The aim of the study was 
to assess the major determinants of low tuberculosis treatment outcome.
Material and methods: A retrospective selective, descriptive, case-control study targeting social, demographic, economic and epidemiological peculiarities, 
case-management, radiological aspects and microbiological characteristics of 437 patients with pulmonary tuberculosis with different outcomes: cured 
and lost to follow-up was performed. Patients’ awareness was established by performing a pre-designed schedule containing open-ended and close-ended 
questions, reflecting knowledge about disease. There were interviewed 151 patients treated after a previous lost to follow-up.
Results: It was established that the major risk factors for loss to follow-up were: the history of detention, migration, patients with MDR-TB, patient’s 
addressing to the hospital, previous history of treatment and social vulnerability. Most of the patients were aware about the disease through the health 
personnel and were satisfied with the received knowledge. The proportion of those who were informed through the mass media was high. They knew 
that tuberculosis is curable with a complete treatment; however, every tenth considered that two-three months are sufficient. 
Conclusions: Raising awareness among patients with high risks about the compliance and the duration of the treatment, emphasizing that the treatment 
is free of charge and will not be started after a previous drop up will improve disease outcome.
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in new cases and 8 months in previously treated cases. Th e 
treatment of the new drug-susceptible patients consists in 
a two phase regimen with four fi rst-line anti-tuberculosis 
drugs [isoniazid (H), rifampicine (R), ethambutol (E) and 
pyrazinamide (Z)] in the intensive phase and two drugs [H 
and R] in the continuation phase [13]. An eight month regi-
men consisted in H, R, E, Z and streptomycine (S) during the 
intensive phase and H, R and E in the continuation phase is 
used for the treatment of previously treated cases (relapses, 
failed and lost to follow-up cases). Multidrug-resistant pa-
tients are treated using the standard regimen for resistant 
tuberculosis that consists of second-line anti-tuberculosis 
drugs during 18 months or more [6]. Th e major contribut-
ing factor of the treatment eff ectiveness represents the right 
combination of the drugs according to the susceptibility 
results [7]. Without an appropriate treatment tuberculosis-
related death occurs in average within 2 years. Due to high 
global epidemiological burden tuberculosis was located on 
the 5th place in the top of the causes of death [13]. Worldwide, 
there were estimated 580.000 new MDR-TB cases in 2015, 
but only 125.000 received an adequate regimen (DOTS-
Plus) [18]. In the Republic of Moldova 25.5% of new cases 
and 70,6% of retreating cases were MDR-TB in 2015 [1]. All 
patients were treated with standard regimen for MDR-TB. 
Th e treatment succes rate in 2014 in the drug-susceptible 
HIV-negative cases constituted 79%, HIV-positive patients 
47% and in multidrug-resistant tuberculosis (MDR-TB) co-
hort 53% [1]. For a better drug-resistance surveillance and 
precocious onset of the correct treatment rapid molecular 
test (GeneXpert MTB/Rif) is used by 15 Moldovan health 
care specialized institutions off ering a 45% sensibility [5, 6]. 
However, the conventional methods: Lowenstein Jenson and 
BACTEC cultures remain the golden standard for Mycobac-
terum tuberculosis complex detection due to the simplicity 
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and low cost [6]. Low treatment adherence and high rate of 
lost to follow-up patients contributed to the development of 
a shorter conventional MDR-TB regimen lasting less than 
12 months with low costs (<1.000$/patient) [18]. It showed 
promising results in selected MDR-TB patients and WHO 
updated its treatment guidelines in 2016 by including the 
recommendation to use the shorter MDR-TB regimen in 
patients with non-complicated tuberculosis (excluding ex-
trapulmonary tuberculosis and pregnancy) [18]. Fluoroqui-
nolones and pyrazinamide are key drugs in the new MDR-
TB regimen, however, surveillance of the cross resistance in 
fi ve high burden countries: Azerbaijan, Bangladesh, Belarus, 
Pakistan and South Africa established that resistance to ri-
fampicine is frequently associated with resistance to pyra-
zinamide, so the eff ectiveness of the short regimen might be 
lower than predicted [13].
According to the WHO estimations MD remains a high 
risk zone showing an inadequate concern regarding tuber-
culosis social determinants that represent major barriers 
in achieving the health related Millennium Development 
Goals [10]. In the actual globalization process, MD is the 
least economically developed country of the Eastern Euro-
pean region. Th e major social determinants of tuberculosis 
and poor outcome are social and economic inequalities, high 
levels of internal/external migration, rapid urbanization and 
population growth in urban areas [4]. Such determinants 
result in the polarization of the public health interventions, 
poor housing, low environmental conditions, malnutrition, 
geographic and cultural barriers in access to the health care 
[11]. A profound interest is paid to the assessment of social 
determinants of low outcome among extremely poor popu-
lations: migrants, Gypsies, drug users, alcohol consumers, 
homeless people, as well as Inuit populations, North Indians, 
Arctic communities in North America [12, 14, 15]. Th ere 
was identifi ed a strong association of overcrowding, social 
isolation, poverty, unhealthy nutrition and persistence of tu-
berculosis in those marginalized populations. 
Th ere are several risk factors predictive of the disease 
outcome. First of all it is the infection with resistant and 
virulent mycobacteria [7]. It depends on the prevalence of 
sick people in the community. It is increased by the over-
crowding, urban residence, poor indoor ventilation and pol-
lution. It can be successfully managed at the administrative 
governmental level and by sanitation agencies. Th e second 
group includes the factors with risk for the disease relapse 
or recrudescence of the latent tuberculosis infection induced 
by such factors: phtysiogenic ages (infants less than 5 years, 
teenagers, elders aged 65 and more), the poverty-related 
conditions that contribute to malnutrition and co-morbid 
state, lack of BCG vaccination [16]. At this level more ef-
fi cient are the activities of the epidemiologic agencies. Th e 
third group of risk factors infl uencing tuberculosis outcome 
are the determinants of the patient’s immune status: HIV 
infection, immune suppressive drugs (>15mg/day of pred-
nisolone for 1 month or more, immune modulators: TNF-α 
blockers or oral steroids, antineoplastic agents), diabetes, 
cancer, silicosis, chronic respiratory diseases, gastrointesti-
nal diseases, underweight, phtysiogenic ages, harmful habits 
(tobacco smoking, alcohol abuse, illicit drug using) [9]. Th e 
most relevant actions for reducing the impact of those con-
ditions must be performed by the primary health care sec-
tor and civil societies, through the active screening of high 
risk groups and their education [2, 3, 8]. Th e fourth group 
infl uencing the fi nal outcome consists of the following risk 
factors: the accessibility of the sick people to the tuberculo-
sis screening and health care, treatment compliance and pa-
tient’s nursing [12]. In this group are included: lack of social 
protection and medical insurance, geographic and economic 
barriers, cultural behavior or stigma. Only the complemen-
tary relationship between primary health care, specialized 
sectors, social and community services can ensure the high-
est eff ectiveness of the disease control.
Th e aim of the study was to assess the determinants of 
loss to follow-up and tuberculosis patient’s awareness. Ob-
jectives were: 1. Comparative assessment of tuberculosis in-
dices in Chisinau and the Republic of Moldova during 2011-
2015. 2. Assessment of the general, social, economic and 
epidemiological risk factors of lost to follow-up tuberculosis 
patients. 3. Evaluation of case-management, diagnosis, ra-
diological aspects and microbiological characteristics of lost 
to follow-up patients.
Material and methods
It was performed a retrospective selective, descriptive 
study targeting social, demographic, economic and epide-
miological peculiarities, case-management, diagnosis, ra-
diological aspects and microbiological characteristics of 437 
patients with pulmonary tuberculosis. Th e electronic system 
for monitoring and follow-up of tuberculosis cases (SIME 
TB) was used for the selection. Data were extracted from the 
statistic templates F089/1-e “Declaration about the patient’s 
established diagnosis of new case/relapse of active tuber-
culosis and restart of the treatment and its outcomes”. Th e 
inclusion criteria were: age > 18 years old, pulmonary tu-
berculosis, signed informed consent. Th e research schedule 
included demographic, social and epidemiological data: sex 
(male/female ratio), age, demographic characteristics (ur-
ban/rural), educational level, economical status (employed, 
unemployed, retired, disabled, student), health insurance 
status (presence/lack), history of migration and detention, 
high risks: close contact with an infectious source, co-mor-
bidities (HIV-infection, diabetes, psychiatric diseases, im-
mune suppressive treatment), health care seeking behavior, 
way of the patient’s detection, patient’s microscopic status. 
All selected patients were diagnosed and managed accord-
ing to the National Clinical Protocol. Enrolled patients were 
distributed in two groups: the 1st group (1) was constituted of 
165 patients successfully treated (cured - CG) in the period 
01.01.2015-31.12.2015 and the 2nd group (2) was constituted 
of 272 patients lost to follow-up (LFUG) in the period of 
01.01.2010-31.1201.2016. 
Population awareness regarding various aspects of tu-
berculosis is important for the disease control at the na-
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tional level. For the assessment of patient’s knowledge was 
performed a pre-designed schedule containing open-ended 
and close-ended questions, refl ecting various aspects of the 
tuberculosis. It included questions on how the patients heard 
about the disease, mode of transmission, symptoms, curabil-
ity, type of drugs, duration of the regimen and the place of 
the treatment. Study technique was by exit interview. Th e 
sample size was constituted from 151 interviewed patients, 
that were 55.51% of the 2nd group. Th ey were informed about 
the purpose of the study, were assured about their confi den-
tiality and anonymity and the informed consent was taken. 
Statistic analysis was carried out using the quantitative and 
qualitative research methods. Statistical survey was per-
formed using Microsoft  Excel XP soft .
Results and discussion
According to the published data by the Moldovan Na-
tional Centre for Management in Health during the period 
2011-2015 it was registered an important decline of all no-
tifi ed cases (new case, retreated for relapse, loss to follow-
up and failure) in MD by 27,8/100.000 and in Chisinau by 
22,2/100.000 population (fi g. 1).
Fig. 1.  Tuberculosis notification rate in MD and 
Chisinau/100.000 during 2011-2015.
Detection of the suspects for tuberculosis is based on the 
microbiological investigation. Ziehl-Neelsen method of acid 
fast bacilli staining and culture on the conventional media 
was performed in the assessment of every patient expos-
ing clinical signs: productive cough for more than 3 weeks, 
weakness, decreased appetite, weight loss, fever and night 
sweats [6]. At least two sputum samples are collected in 8-24 
hour interval, one sample being an early morning speci-
men [6]. However, the poor sensitivity of smear microscopy 
(less than 25%) and long delay in obtaining culture results 
(at least 120 days for providing a positive result) contribute 
to the late detection and increased proportion of severe and 
chronic forms of pulmonary tuberculosis [5]. Th e high rate 
of drug-resistant strains circulating in the population made 
compulsory the performing the nucleic acid amplifi cation 
testing (GeneXpert MTB/Rif) to each suspected case [6]. 
By including the polymerase chain reaction in the standard 
algorithm was increased the sensibility of suspect’s investi-
gation [6]. As the consequence the rate of pulmonary clini-
cal forms of tuberculosis is the highest among all diagnosed 
forms and maintains the similar value in the assessed period 
of time (fi g. 2).
Fig. 2.  Rate of pulmonary TB in MD and Chisinau 
during 2011-2015 (%).
Due to the improving of the treatment quality, the rate of 
died MDR-TB patients was continuously decreasing: 2011 
– 51.7%, 2012 – 47.2%, 2013 – 46%, 2014 – 34.6%, 2015 – 
23.2%. Th e treatment success rate increased (by 3.7%) from 
2010 to 2014 in the microscopic positive patients: 2010 – 
45%, 2011 – 56.7%, 2012 – 57.5% and culture positive cases 
2013 – 70.3%, 2014 – 78.7% (fi g. 3).
Fig. 3.  Treatment success rate in MD and Chisinau 
during 2011-2015 (%).
Th e treatment failure rate showed a sharp decrease from 
2010 to 2015 due to defi nition changes: 2010 – 26.9%, 2011 
– 23.6% and 2012 – 18.2%. During this period of time all 
cases identifi ed with MDR-TB and performing treatment for 
drug-susceptible TB were considered a therapeutic failure. 
Starting from 2013 patients with treatment failure were con-
sidered only patients with microbiological smear positive 
aft er 5 months of treatment. Actually the rate of treatment 
failure is very low: 2013 – 6% and 2014 – 2.8%. Th e rate of 
patients lost to follow-up decreased evidently: 2010 – 15.8%, 
2011 – 16%, 2012 – 13.7%, 2013 – 9.3% and 2014 – 11.2%.
Th e proportion of patients lost to follow-up decreased 
during the period 2010-2015 by 16.4% in MD and by 4.7% 
in Chisinau due to implementation of the patient’s centered 
health care (fi g. 4). 
Fig. 4.  Rate of lost to follow-up patients in MD and Chisinau 
during 2011-2015 (%).
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Clinical study established a similar sex distribution in the 
cured (the 1st group) and lost to follow-up group (the 2nd gro-
up), with male/female ratio=4/1 in the 1st group and 3,86/1 in 
the 2nd group. Repartition of the patients into three age groups, 
identified that the largest was 35-54 year group, consisting 
from one half of every sample. Comparing the groups it was 
established that the rate of young, economically vulnerable 
and reproductive patients (aged 18-34) predominated in the 
2nd group: 121 (44.48%) vs. 40 (24.24%) in the 1st group. Older 
patients (aged 55 and more) predominated in the 1st group. 
So, according to the biological characteristics of the selected 
patients it was established that men and women had the 
same probability to be cured or to default the treatment, but 
young cases have a higher risk for default than older patients. 
When distributing patients by demographic residence it was 
established a high predominance of rural residents in the lost 
to the follow-up group.
Table 1
Distribution of patients by demographic data
Indices
Sex
Age
Residence  
CG (1) LFUG (2)
P valueN= 165 
(P %)
N= 272(P %)
Sex Men 132 (80.00) 216 (79.41) >0,05
Women 33 (20.00) 56 (20.58) >0,05
Age groups 18-34 years 40 (24.24) 121 (44.48) <0,001
35-54 years 91 (55.15) 137 (50.37) >0,05
> 55 years 34 (20.61) 14 (5.15) <0,001
Residence Urban 134 (81.21) 42 (15.44) <0,001
Rural 31 (18.78) 229 (84.51) <0,001
When distributing the patients, according to the case-type 
it was established a higher rate of new cases in the 1st than in 
the 2nd group, without achieving statistical threshold. Relapse 
was in every fifth patient from both groups. Patients with a 
previous loss to follow-up statistically predominated in the 
2nd group. The totality of the retreated patients predominated 
in the 2nd group – 116 (42.65%) comparing with 53 (32.12%) 
cases in the 1st group (p<0,05). Data are shown in the table 2.
Table 2
Distrbution in case-type according to the previous 
tuberculosis treatment history
Characteristics
N= 165 (P %)
CG (1) LFUG (2)
P value
N= 272(P %)
New case (never treated) 112 (67.88) 156 (57.35) >0,05
Retreat-
ment 
Relapse 35 (21.21) 49 (18.01) >0,05
After loss to 
follow-up
8 (4.85)
52 (19.12)
<0,05
After 
treatment 
failure
10 (6.06)
15 (5.51)
>0,05
When distributing patients, according to the economic 
status, it was established that employed persons, contributing 
to the health budget by paying taxes, health insurance policy 
and social taxes predominated in the 1st group. The low rate of 
disabled patients in all groups demonstrated that most of them 
had no social protection and financial aid. Unemployed pati-
ents constituted the largest part of the 2nd group and one half of 
the 1st group. Patients in social vulnerable state, that included 
unemployed, disabled, retired and students predominated in 
2nd group: 254 (93.38%) comparing with 124 (75.15%) cases, 
p<0,001. Patients without insurance were more numerous in 
the 2nd group (tab. 3). 
Table 3
Economic status of patients with pulmonary tuberculosis
Economic 
indices
State
CG (1) LFUG (2)
P value
N= 165 (P %) N= 272(P %)
Stable Employed 41 (24.85) 18 (6.62) <0,001
Disabled 9 (5.45) 16 (5.88) >0,05
Retired 12 (7.27) 4 (1.47) >0,05
Students 8 (4.85) 0 >0,05
Vulnerable Unemployed 95 (57.57) 234 (86.03) <0,001
Lack of 
insurance
97 (57.57) 234 (86.03) <0,001
When assessing the educational level it was established 
that one half of the 2nd group and one third of the 1st group 
graduated general school. The incomplete general studies 
had more frequently the patients from the 2nd group. Higher 
education was established in a limited number of cases. The 
totality of patients with low level of education which included 
no school attendance, primary and incomplete general school 
predominated in the 2nd group: 90 (33.09%) comparing with 
45 (27.73%) cases in the 1st group. Exposed data are revealed 
in the table 4.
Table 4
Distribution of patients according to the last 
graduated level
Educational 
level
Educational status
CG (1) LFUG (2)
P valueN= 165 
(P %)
N= 272
(P %)
Illiteracy No school atten-
dance
1 (0.61) 9 (3.31) >0,05
Primary level Primary & general 
incomplete school 
44 (26.67) 81 (29.79) >0,05
Secondary 
level
Completed gen-
eral school
57 (34.4) 147 
(54.04)
<0,001
Professional school 47 (28.48) 31 (11.39) <0,001
Higher edu-
cation
Superior studies 16 (9.69) 4 (1.47) >0,05
When distributing patients in high risk groups, it was de-
termined that poor living conditions and extreme poverty (ho-
meless) predominated in the 2nd group. History of migration 
during the last year and history of imprisonment statistically 
predominated in the 2nd group. The lowest rate of the family 
TB clusters affiliated to each investigated patient was linked 
with the low quality of epidemiological cross-examination. 
Patients with associated diseases were every fourth from 
each group. Among associated diseases, HIV infection was 
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established in a similar proportion in both groups. Chronic 
alcohol abusers were 26 (9.59%), drug users – 5 (1.84%) and 
psychiatric disorders had 4 (1.47%) patients in the 2nd group. 
No such cases were established in the 1st group. Data are 
shown in the table 5.
Table 5
Distribution of patients in high risk groups
Risk  groups 
CG (1) LFUG (2)
P value
N= 165 (P %) N= 272(P %)
Poor living condi-
tions
42 (25.45) 127 (46.69) <0,001
Homelessness 12 (7.27) 36 (13.23) >0,05
Migration 20 (12.12) 70 (25.73) <0,001
History of detention 3 (1.81) 56 (20.58) <0,001
Closed contact 4 (2.42) 19 (6.98) >0,05
Associated diseases 42 (25.45) 72 (26.47) >0,05
HIV infection 15 (9.09) 25 (9.19) >0,05
Studying case-management, it was identified that the staff 
of the primary health care detected one half of the 1st group 
and every fourth patient in the 2nd group as symptomatic cases. 
The rate of patients detected by the high risk groups screen-
ing was low and demonstrated poor control of the vulnerable 
populations. Pulmonologists diagnosed as symptomatic and 
by high risk group screening a low rate of patients from both 
groups. Direct addressing to the specialized hospitals was 
used more frequently by the patients from the 2nd group due 
to the lack of health insurance and avoidance of primary 
health care staff. Other ways of detection were rarely used 
and included detection of patients hospitalized in the clinical 
hospital (tab. 6).
Table 6
Case-management characteristics of selected patients
Health  level Detection ways 
CG (1) LFUG (2)
P 
valueN= 165 
(P %)
N= 272
(P %)
PHC Detected by GPs as 
symptomatic cases
69 (41.82)
73 (26.83) <0,01
Detected by GPs 
through the scree-
ning of HRG
30 (18.18)
35 (12.87) >0,05
Ambulatory 
specialised 
level
Detected by SP as 
symptomatic cases
22 (13.33)
31 (11.39) >0,05
Detected by SP 
through the scree-
ning of HRG
11 (6.67)
23 (8.45) >0,05
Hospital 
level
Direct addressing 
to the specialized 
hospital 
30 (18.18)
107 
(39.34)
<0,001
Other Other ways 3 (1.82) 3 (1.11) >0,05
Note: PHC-primary health care, GPs-general practitioners, SP-specialist 
pneumophtysiologist, HRG-high risk groups.
When identifying the clinical radiological forms of 
pulmonary tuberculosis it was established that infiltrative 
tuberculosis was diagnosed in the most of the patients of both 
samples, however, it predominated in the 1st group. Severe, 
chronic forms, which included disseminated, generalized and 
fibro-cavernous tuberculosis predominated in the 2nd group 
– 41 (15.07%) comparing with 11 (6.67%) patients in the 1st 
group, p<0,01. Distributing patients, according to the num-
ber of the affected lungs, it was established that one lung was 
involved in two thirds of the 2nd and one half of the 1st group 
and both lungs were affected in two thirds of the 2nd group 
and one half of the 1st group. Destructive forms of pulmonary 
tuberculosis were identified in a similar proportion in both 
groups. Extrapulmonary localizations were identified only in 
the 2nd group (tab. 7).
Table 7
Distribution of patients according to the radiological 
characteristics
Parameters Detection ways 
CG (1) LFUG (2)
P 
valueN= 165 
(P %)
N= 272
(P %)
Forms of TB PIT 154 (93.33) 223 (81.98) >0,05
PDT 9 (5.45) 21 (7.72) >0,05
Generalized TB 0 1 (0.36) >0,05
FCVTB 2 (1.21) 19 (6.98) >0,05
Localization 
and features 
1 lung 90 (54.54)  61 (22.42) <0,001
Both lungs 75 (45.54) 211 (77.57) <0,001
Lung destruc-
tion 79 (47.88)
150 (55.15) >0,05
Extrapulmo-
nary
Pleurisy 0 3 (1.11) >0,05
Other forms 0 5 (1.84) >0,05
Note: PIT – pulmonary infiltrative tuberculosis, PDT- pulmonary 
disseminated tuberculosis, FCVTB – fibro-cavernous tuberculosis.
When assessing the laboratory features it was identified 
that one half of both samples were microscopic positive for 
acid-fast-bacilli. Culture positive have been more numerous 
patients from the 2nd group. Multidrug-resistance was esta-
blished in one third of the 2nd group and every tenth patient 
from the 1st group. Drug sensitivity testing identified a low 
proportion of patients with mono- and poly-resistant tuber-
culosis in both groups (tab. 8).
Table 8
Distribution of patients according 
to the microbiological features
Characteristics
N= 165 (P %)
CG (1) LFUG (2)
P valueN= 272
(P %)
Microbio-
logical
Microscopic positive 86 (52.12) 149 (54.78) >0,05
Culture positive 73 (44.24) 156 (57.35) <0,01
MDR-TB 22 (13.33) 79 (29.04) <0,001
Mono-resistance 6 (3.64) 3 (1.11) >0,05
Poly-resistance 4 (2.42) 6 (2.26) >0,05
GeneXpert 
MTB/Rif
Sensible 98 (59.39) N/A -
Resistant 15 (9.09) N/A -
GeneXpert MTB/Rif 
positive
117 (70.91)
N/A
-
An important research outcome represents the calcu-
lation of the likelihood ratio, relative risk (RR), odds ratio 
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(OR) and the attributable risk (AR). Th ey were used for 
identifying the high risk groups targeted for the priority in-
terventions for reducing the probability of loss to follow-up. 
All risk factors exposed statistical diff erence between groups. 
Th e hierarchy of risk groups according to the probability 
(likelihood ratio) to default the treatment had patients from 
rural areas, living in poor conditions, with the life history 
of detention, unemployed and those who addressed to the 
specialized hospitals avoiding the primary health care. Ma-
jor factors assessed through relative risk and odds ratio were: 
life history of detention, rural residence, poverty, unemploy-
ment and direct addressing to the hospital. According to the 
attributable risk hierarchy of risk groups was: life history of 
detention, rural residence, recent history of migration, pa-
tients with MDR-TB, direct addressing to the hospital, pov-
erty, previously treated patients and unemployment. Data 
are shown in the table 8.
Table 8
Risk factors of tuberculosis patients for loss to follow-up
Factors
P
Statistical indices AR
LR RR OR %
Demo-
graphic
Rural resi-
dence
0 194,966 6,38 23,56 80.98
Treatment Previously 
treated
0,02 4,85 1,33 1,57 43.96
Social 
economical 
features
Unemploy-
ment
0 43,77 2,24 5,53 33.08
Poverty 0 171,029 5,3 18,31 45.49
Migration 0,0006 12,358 1,88 2,51 52.89
History of 
detention
0 101,51 3,29 46,07 91.20
Case-
related
Direct 
addressing 
to the 
hospital
0 76,49 2,57 8,16 53.78
MDR-TB 0,00016 15,141 1,93 2,66 54.09
Note: P value according to the Pearson’s test, LR-likelihood ratio, RR-
relative risk, OR-odds ratio; AR-attributable risk.
Population awareness regarding various aspects of tu-
berculosis is important for the disease control at the na-
tional level. For the assessment of patient’s knowledge was 
performed a pre-designed schedule containing open-ended 
and close-ended questions, refl ecting various aspects of the 
tuberculosis. It included questions on how the patients heard 
about the disease, mode of transmission, symptoms, curabil-
ity, type of drugs, duration of the regimen and the place of 
the treatment. Study technique was by exit interview. Th e 
sample size was constituted from 151 interviewed patients. 
Th ey were informed about the purpose of the study, were 
assured about their confi dentiality and anonymity and the 
informed consent was taken. 
When the patients were asked about how they received 
information related to tuberculosis it was revealed that most 
of all [121 (80%)] were informed by the health personnel. 
About 30 (19.87%) had heard from an informal contact: 17 
(11%) mass media (radio, television, posters), 8 (5%) family 
and 5 (4%) from friends (fi gure 5). When they were asked if 
they were satisfi ed by the conversation with health personnel 
about their disease 141 (51,845) answered “yes”.
Fig. 5.  Distribution of the patients according to the source of 
knowledge (abs., %).
When the patients were asked about the cause of tuber-
culosis, 142 (94.04%) answered “infection”. Regarding the 
mode of the spread of infection most of them, 132 (87.42%) 
patients, answered, correctly choosing multiple choice: 
cough, spit, speaking and talking face-to-face with a sick 
person (fi g. 6).
Fig. 6.  Distrbution of patients according to the knowledge about 
the mode of the spread of infection (abs.,%).
Th e patients were asked about which organ can be aff ect-
ed by tuberculosis. Most of them [140 (92.72%)] answered 
“lung” and only a low proportion “lungs and other organs” 
(fi g. 7).
Fig. 7.  Distrbution of the patients according to knowledge about 
the affected by tuberculosis organs (abs.,%).
When they were asked if the disease is curable, 140 
(92.71%) patients answered “yes”, but only 52 (34.44%) rec-
ognized that were previously treated for tuberculosis. For the 
establishing the patient’s therapeutic compliance they were 
asked if there is a risk to develop resistance if the treatment 
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is taken irregularly or interrupted. Only 110 (72.85%) pa-
tients answered “yes”. Th ey were asked if the smear micros-
copy is negative, it is allowed to interrupt the treatment and 
16 (10.59%) patients answered correctly “yes”. At the ques-
tion if they can take two dosages if the previous dosage was 
lost, 143 (94.71%) patients answered correctly “no”.  When 
asked how many months it is necessary to be treated to be 
cured, 77 (50.99%) said “more than 6 months”, 55 (36.42%) 
– ”more than one year”,  8 (5.29%) – “two-three months” and 
11 (7.28%) did not answer. Th ey were asked where they want 
to be treated and 111 (73.51%) answered “in the hospital” 
and only 40 (26.49%) in outpatient settings.
Conclusions
Th e standard treatment of a new drug-susceptible case, 
according to WHO guidelines, lasts 6 months and of drug-
resistant case – 18-24 months. It must achieve a treatment 
success rate of at least 85%. Long duration, the high rate of 
drug adverse reactions and low patient’s awareness about 
treatment compliance contribute to loss to follow-up of at 
least every tenth patient in MD.
Th e tuberculosis notifi cation rate in MD decreased evi-
dently in the last 5 years due to the low rate of sreening per-
formed in the high risk groups. Th e treatment success rate in 
MD increased evidently due to the excluding of the MDR-
TB group from the general cohort. Th e rate of lost to follow-
up patients remains high in Chisinau, despite an evident de-
crease in the entire country.
No diff erences were identifi ed distributing patients, ac-
cording to the sex. Younger patients were more frequent 
among those who drop up the treatment, but older patients 
were more frequently cured. Rural residence was associated 
with loss to follow-up, probably due to low accessibility to 
specialized health care settings.
Patients previously treated, constituted one half of the 
lost to the follow-up group. Treated aft er a previous loss to 
follow-up was every fi ft h patient.
Most of the patients from the lost to follow-up group 
were economically vulnerable. Lack of health insurance and 
social vulnerability constituted the major barriers for health 
care seeking. Low level of education had one third of both 
samples.
Patients from high risk groups designed by the national 
policy (HIV-infected, close contacts) represented only every 
tenth case. Th e highest proportion constituted TB-HIV co-
infected patients. However, high risks such as poverty and 
comorbid status were established in every second patient 
from the group of lost to follow-up.
Cured patients were detected by general practitioner 
more frequently and patients treated aft er loss to follow-up 
came to the specialized hospitals avoiding primary health 
care. Severe forms, involving both lungs complicated with 
extrapulmonary localizations have been more frequent in 
the group of the lost to follow-up patients. 
Th e proportion of bacteriological positive and drug-
resistant patients was the highest in the lost to follow-up 
group, demonstrating the epidemiological danger that they 
expose on the healthy population.
Th e hierarchy of risk groups according to the highest 
proportion was established: ex-detainees, rural residents, 
migrants, infected with drug-resistant strains, addressed to 
the hospital, poor cases, unemployed and previously treated.
Th e awareness of the patients was good. Most of them 
were informed by the health personnel and were satisfi ed by 
the received knowledge. Th e proportion of those who were 
informed through the mass media was high. Most of the pa-
tients knew that the disease is contagious, is spread through 
the air and aff ects the lungs.
Despite the received information, every third patient lied 
that had never been treated before, all of them being patients 
treated aft er loss to follow-up. Most of the patients knew that 
the disease is curable with a complete treatment; however, 
every tenth considered that two-three months are suffi  cient. 
Considering their economic vulnerability two thirds wanted 
to be treated in the hospital. 
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